AstraZeneca to cut a further 7,300 jobs This is AstraZeneca's third restructuring programme since 2007.

Anglo-Swedish drugs maker AstraZeneca has announced a further 7,300 job cuts over the next two years as part of a new restructuring programme.

The GMB Union has said 250 to 300 of the cuts will be in R&D at the firm's site in Alderley Park, Cheshire.

It also said there would be unspecified back office cuts at other UK sites.